FDA Approved: TAUVID — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

FDA approved a supplemental application for TAUVID (flortaucipir F-18) from Eli Lilly, updating its labeling and/or indication. TAUVID is a PET imaging agent us…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Tauvid (Flortaucipir (18F))

Snippet

SUPPL AP for TAUVID (FLORTAUCIPIR F-18)